- Home
- ICCM vs PTHL Comparison
ICCM vs PTHL Comparison
Compare ICCM & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- PTHL
- Stock Information
- Founded
- ICCM 2006
- PTHL 1998
- Country
- ICCM Israel
- PTHL China
- Employees
- ICCM N/A
- PTHL N/A
- Industry
- ICCM
- PTHL
- Sector
- ICCM
- PTHL
- Exchange
- ICCM Nasdaq
- PTHL Nasdaq
- Market Cap
- ICCM 72.4M
- PTHL 60.5M
- IPO Year
- ICCM N/A
- PTHL 2024
- Fundamental
- Price
- ICCM $1.21
- PTHL $3.62
- Analyst Decision
- ICCM Strong Buy
- PTHL
- Analyst Count
- ICCM 2
- PTHL 0
- Target Price
- ICCM $2.70
- PTHL N/A
- AVG Volume (30 Days)
- ICCM 441.2K
- PTHL 40.8K
- Earning Date
- ICCM 11-26-2024
- PTHL 02-11-2025
- Dividend Yield
- ICCM N/A
- PTHL N/A
- EPS Growth
- ICCM N/A
- PTHL N/A
- EPS
- ICCM N/A
- PTHL N/A
- Revenue
- ICCM $3,671,000.00
- PTHL $572,291.00
- Revenue This Year
- ICCM $10.03
- PTHL N/A
- Revenue Next Year
- ICCM $62.68
- PTHL N/A
- P/E Ratio
- ICCM N/A
- PTHL N/A
- Revenue Growth
- ICCM 26.02
- PTHL 2.32
- 52 Week Low
- ICCM $0.48
- PTHL $3.32
- 52 Week High
- ICCM $1.57
- PTHL $6.45
- Technical
- Relative Strength Index (RSI)
- ICCM 60.15
- PTHL N/A
- Support Level
- ICCM $1.16
- PTHL N/A
- Resistance Level
- ICCM $1.27
- PTHL N/A
- Average True Range (ATR)
- ICCM 0.10
- PTHL 0.00
- MACD
- ICCM -0.02
- PTHL 0.00
- Stochastic Oscillator
- ICCM 41.64
- PTHL 0.00
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.